180 related articles for article (PubMed ID: 34890987)
1. Comparison of the mechanisms of estrogen disrupting effects between triphenyl phosphate (TPhP) and tris(1,3-dichloro-2-propyl) phosphate (TDCIPP).
Ji X; Li N; Ma M; Li X; Zhu K; Rao K; Wang Z; Wang J; Fang Y
Ecotoxicol Environ Saf; 2022 Jan; 229():113069. PubMed ID: 34890987
[TBL] [Abstract][Full Text] [Related]
2. Complex Interplay Among Nuclear Receptor Ligands, Cytosine Methylation, and the Metabolome in Driving Tris(1,3-dichloro-2-propyl)phosphate-Induced Epiboly Defects in Zebrafish.
Dasgupta S; Vliet SMF; Cheng V; Mitchell CA; Kirkwood J; Vollaro A; Hur M; Mehdizadeh C; Volz DC
Environ Sci Technol; 2019 Sep; 53(17):10497-10505. PubMed ID: 31385694
[TBL] [Abstract][Full Text] [Related]
3. Estrogenic and growth inhibitory responses to organophosphorus flame retardant metabolites in zebrafish embryos.
Lee JS; Kawai YK; Morita Y; Covaci A; Kubota A
Comp Biochem Physiol C Toxicol Pharmacol; 2022 Jun; 256():109321. PubMed ID: 35227875
[TBL] [Abstract][Full Text] [Related]
4. Derivation of aquatic predicted no-effect concentration and ecological risk assessment for triphenyl phosphate and tris(1,3-dichloro-2-propyl) phosphate.
Ai S; Li J; Wang X; Zhao S; Ge G; Liu Z
Sci Total Environ; 2024 Feb; 913():169756. PubMed ID: 38171460
[TBL] [Abstract][Full Text] [Related]
5. In vitro endocrine disruption potential of organophosphate flame retardants via human nuclear receptors.
Kojima H; Takeuchi S; Itoh T; Iida M; Kobayashi S; Yoshida T
Toxicology; 2013 Dec; 314(1):76-83. PubMed ID: 24051214
[TBL] [Abstract][Full Text] [Related]
6. The Flame-Retardant Tris(1,3-dichloro-2-propyl) Phosphate Represses Androgen Signaling in Human Prostate Cancer Cell Lines.
Reers AR; Eng ML; Williams TD; Elliott JE; Cox ME; Beischlag TV
J Biochem Mol Toxicol; 2016 May; 30(5):249-57. PubMed ID: 26709203
[TBL] [Abstract][Full Text] [Related]
7. In vitro estrogen-disrupting effects of organophosphate flame retardants.
Ji X; Li N; Ma M; Rao K; Wang Z
Sci Total Environ; 2020 Jul; 727():138484. PubMed ID: 32330712
[TBL] [Abstract][Full Text] [Related]
8. Bone developmental toxicity of organophosphorus flame retardants TDCIPP and TPhP in marine medaka Oryzias melastigma.
Hong H; Zhao Y; Huang L; Zhong D; Shi D
Ecotoxicol Environ Saf; 2021 Oct; 223():112605. PubMed ID: 34371453
[TBL] [Abstract][Full Text] [Related]
9. Levels of Urinary Metabolites of Organophosphate Flame Retardants, TDCIPP, and TPHP, in Pregnant Women in Shanghai.
Feng L; Ouyang F; Liu L; Wang X; Wang X; Li YJ; Murtha A; Shen H; Zhang J; Zhang JJ
J Environ Public Health; 2016; 2016():9416054. PubMed ID: 28115951
[TBL] [Abstract][Full Text] [Related]
10. Development of a rat physiologically based kinetic model (PBK) for three organophosphate flame retardants (TDCIPP, TCIPP, TCEP).
Deepika D; Sharma RP; Schuhmacher M; Kumar V
Toxicol Lett; 2023 Jul; 383():128-140. PubMed ID: 37356742
[TBL] [Abstract][Full Text] [Related]
11. Impact of dietary exposure to low-dose tris(1,3-dichloro-2-propyl)phosphate in allergic asthmatic mice.
Yanagisawa R; Koike E; Win-Shwe TT; Kawaguchi M; Takano H
Immunopharmacol Immunotoxicol; 2021 Oct; 43(5):599-610. PubMed ID: 34388063
[TBL] [Abstract][Full Text] [Related]
12. In vitro biotransformation of tris(1,3-dichloro-2-propyl) phosphate and triphenyl phosphate by mouse liver microsomes: Kinetics and key CYP isoforms.
Chen MH; Zhang SH; Jia SM; Wang LJ; Ma WL
Chemosphere; 2022 Feb; 288(Pt 1):132504. PubMed ID: 34627810
[TBL] [Abstract][Full Text] [Related]
13. Prenatal exposure to emerging and traditional organophosphate flame retardants: Regional comparison, transplacental transfer, and birth outcomes.
Luo W; Liu Y; Yang X; Aamir M; Bai X; Liu W
Environ Pollut; 2023 Nov; 336():122463. PubMed ID: 37669697
[TBL] [Abstract][Full Text] [Related]
14. Endocrine disruption potentials of organophosphate flame retardants and related mechanisms in H295R and MVLN cell lines and in zebrafish.
Liu X; Ji K; Choi K
Aquat Toxicol; 2012 Jun; 114-115():173-81. PubMed ID: 22446829
[TBL] [Abstract][Full Text] [Related]
15. An adverse outcome pathway based in vitro characterization of novel flame retardants-induced hepatic steatosis.
Negi CK; Bajard L; Kohoutek J; Blaha L
Environ Pollut; 2021 Nov; 289():117855. PubMed ID: 34340181
[TBL] [Abstract][Full Text] [Related]
16. Longer commutes are associated with increased human exposure to tris(1,3-dichloro-2-propyl) phosphate.
Reddam A; Tait G; Herkert N; Hammel SC; Stapleton HM; Volz DC
Environ Int; 2020 Mar; 136():105499. PubMed ID: 31999975
[TBL] [Abstract][Full Text] [Related]
17. Developmental circulatory failure caused by metabolites of organophosphorus flame retardants in zebrafish, Danio rerio.
Lee JS; Morita Y; Kawai YK; Covaci A; Kubota A
Chemosphere; 2020 May; 246():125738. PubMed ID: 31918085
[TBL] [Abstract][Full Text] [Related]
18. The Organophosphate Esters Used as Flame Retardants and Plasticizers Affect H295R Adrenal Cell Phenotypes and Functions.
Li Z; Robaire B; Hales BF
Endocrinology; 2023 Aug; 164(9):. PubMed ID: 37522340
[TBL] [Abstract][Full Text] [Related]
19. Assessment of tris (1, 3-dichloro-2-propyl) phosphate toxicology in PC12 cells by using digital gene expression profiling.
Li L; Jiang S; Li K; Lin B; Wang Z; Zhang Z; Fang Y
Chemosphere; 2017 Sep; 183():353-360. PubMed ID: 28554019
[TBL] [Abstract][Full Text] [Related]
20. Current-use flame retardants: Maternal exposure and neurodevelopment in children of the CHAMACOS cohort.
Castorina R; Bradman A; Stapleton HM; Butt C; Avery D; Harley KG; Gunier RB; Holland N; Eskenazi B
Chemosphere; 2017 Dec; 189():574-580. PubMed ID: 28963974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
